Femoral-deep femoral crossover bypass for unilateral iliofemoral arteriosclerosis obliterans
10.3760/cma.j.issn.1007-631X.2012.11.011
- VernacularTitle:股-股深动脉人工血管旁路术治疗单侧长段髂股动脉硬化闭塞症
- Author:
Tao MA
;
Jie MA
;
Qingsheng LU
;
Zhiqing ZHAO
;
Junmin BAO
;
Xiang FENG
;
Rui FENG
;
Zaiping JING
- Publication Type:Journal Article
- Keywords:
Arterial occlusive diseases;
Vascular surgical procedures;
Blood vessel prosthesis;
Extra-anatomic bypass
- From:
Chinese Journal of General Surgery
2012;(11):893-895
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical results of femoral-deep femoral crossover bypass in the treatment of long-segment unilateral iliac artery occlusive disease.Methods From July 1995 to December 2010,40 patients (28 males,12 females,aged from 66 to 90,with mean age of 73) with comprehensive unilateral iliac-superficial femoral arteriosclerosis obliterans were enrolled in this procedure.All patients suffered from unilateral common iliac,external iliac,common femoral,and superficial femoral arteriosclerosis obliterans.These patients were treated with femoral-deep femoral crossover bypass.Postoperative ankle-brachial index,blood flow velocity and patency rates in 5,7 and 10 years and limb salvage rates in 5,7 and 10 years were evaluated.Results There was no perioperative mortality nor extremity amputation.35 (87.5％ ) patients were followed-up from 1 to 13 years (mean 5.7 y).Anklebrachial index rose from preoperative 0.23 ± 0.10 to postoperative 0.55 ± 0.11 (t =15.91,P =0.000 ).Popliteal arterial velocity rose from preoperative ( 14 ±6) cm/s to postoperative (34 ± 10) cm/s (t =15.63,P =0.000) ; Tibial arterial velocity rose from ( 10 ±4) cm/s to (22 ±7) cm/s (t =15.71,P =0.000).The primary and secondary patency rates were 60.1％,44.3％,25.3％,and 93.5％,86.8％,57.9％ at 5,7 and 10 years,respectively.Limb salvage rates were 97.5％,95％,and 90％,at 5,7 and 10 years,respectively.Conclusions Femoral-deep femoral crossover bypass is safe and reliable in treating certain unilateral iliofemoral occlusive disease,especially for high-risk old patients or those who are not indicated for endovascular therapies or direct aortic approaches.
